Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Other Non-Current Assets (2020 - 2026)

Maxcyte has reported Other Non-Current Assets over the past 6 years, most recently at $2.5 million for Q4 2025.

  • Quarterly Other Non-Current Assets rose 61.03% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 61.03% year-over-year, with the annual reading at $2.5 million for FY2025, 61.03% up from the prior year.
  • Other Non-Current Assets was $2.5 million for Q4 2025 at Maxcyte, down from $2.6 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $2.8 million in Q2 2025 and troughed at $295000.0 in Q1 2024.
  • The 5-year median for Other Non-Current Assets is $920500.0 (2022), against an average of $1.1 million.
  • Year-over-year, Other Non-Current Assets soared 834.22% in 2021 and then crashed 62.15% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $316700.0 in 2021, then surged by 155.45% to $809000.0 in 2022, then plummeted by 52.04% to $388000.0 in 2023, then skyrocketed by 294.85% to $1.5 million in 2024, then skyrocketed by 61.03% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Other Non-Current Assets are $2.5 million (Q4 2025), $2.6 million (Q3 2025), and $2.8 million (Q2 2025).